Literature DB >> 27474865

Modeling the protonation states of β-secretase binding pocket by molecular dynamics simulations and docking studies.

Dima A Sabbah1, Haizhen A Zhong2.   

Abstract

β-secretase (BACE1) is an aspartyl protease that processes the β-amyloid peptide in the human brain in patients with Alzheimer's disease. There are two catalytic aspartates (ASP32 and ASP228) in the active domain of BACE1. Although it is believed that the net charge of the Asp dyad is -1, the exact protonation state still remains a matter of debate. We carried out molecular dynamic (MD) simulations for the four protonation states of BACE1 proteins. We applied Glide docking studies to 21 BACE1 inhibitors against the MD extracted conformations. The dynamic results infer that the protein/ligand complex remains stable during the entire simulation course for HD32D228 model. The results show that the hydrogen bonds between the inhibitor and the Asp dyad are maintained in the 10,000th ps snapshot of HD32D228 model. Our results also reveal the significant loop residues in maintaining the active binding conformation in the HD32D228 model. Molecular docking results show that the HD32D228 model provided the best enrichment factor score, suggesting that this model was able to recognize the most active compounds. Our observations provide an evidence for the preference of the anionic state (HD32D228) in BACE1 binding site and are in accord with reported computational data. The protonation state study would provide significant information to assign the correct protonation state for structure-based drug design and docking studies targeting the BACE1 proteins as a tactic to develop potential AD inhibitors.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; BACE1; Molecular docking; Molecular dynamic simulation; Protonation state; β-secretase

Mesh:

Substances:

Year:  2016        PMID: 27474865     DOI: 10.1016/j.jmgm.2016.07.005

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  3 in total

1.  Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer.

Authors:  Vinod Kumar; Amit Kumar Chaudhary; Yuxiang Dong; Haizhen A Zhong; Goutam Mondal; Feng Lin; Virender Kumar; Ram I Mahato
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

2.  Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target.

Authors:  Suliman Almahmoud; Xiaofang Wang; Jonathan L Vennerstrom; Haizhen A Zhong
Journal:  Molecules       Date:  2019-06-07       Impact factor: 4.411

Review 3.  Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer's Disease.

Authors:  Sudip Dhakal; Naufal Kushairi; Chia Wei Phan; Benu Adhikari; Vikineswary Sabaratnam; Ian Macreadie
Journal:  Int J Mol Sci       Date:  2019-10-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.